In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature
- PMID: 11469757
- DOI: 10.1023/a:1010954803886
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature
Abstract
Voriconazole (VfendTM) is a new triazole that currently is undergoing phase III clinical trials. This review summarizes the published data obtained by NCCLS methods on the in vitro antifungal activity of voriconazole in comparison to itraconazole, amphotericin B, fluconazole, ketoconazole and flucytosine. Voriconazole had fungistatic activity against most yeasts and yeastlike species (minimum inhibitory concentrations [MICs] < 2 microg/ml) that was similar or superior to those of fluconazole, amphotericin B, and itraconazole. Against Candida glabrata and C. krusei, voriconazole MIC ranges were 0.03 to 8 and 0.01 to > 4 microg/ml, respectively. For four of the six Aspergillus spp. evaluated, voriconazole MICs (< 0.03 to 2 microg/ml) were lower than amphotericin B (0.25 to 4 microg/ml) and similar to itraconazole MICs. Voriconazole fungistatic activity against Fusarium spp. has been variable. Against E oxysporum and F. solani, most studies showed MICs ranging from 0.25 to 8 microg/ml. Voriconazole had excellent fungistatic activity against five of the six species of dimorphic fungi evaluated (MIC90s < 1.0 microg/ml). The exception was Sporothrix schenckii (MIC90s and geometric mean MICs > or = 8 microg/ml). Only amphotericin B had good fungistatic activity against the Zygomycetes species (voriconazole MICs ranged from 2 to > 32 microg/ml). Voriconazole showed excellent in vitro activity (MICs < 0.03 to 1.0 microg/ml) against most of the 50 species of dematiaceous fungi tested, but the activity of all the agents was poor against most isolates of Scedosporium prolificans and Phaeoacremonium parasiticum (Phialophora parasitica). Voriconazole had fungicidal activity against most Aspergillus spp., B. dermatitidis, and some dematiaceous fungi. In vitro/in vivo correlations should aid in the interpretation of these results.
Similar articles
-
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001. J Clin Microbiol. 2001. PMID: 11230410 Free PMC article.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
-
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.J Antimicrob Chemother. 1998 Dec;42(6):741-5. doi: 10.1093/jac/42.6.741. J Antimicrob Chemother. 1998. PMID: 10052897
-
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.Antimicrob Agents Chemother. 2006 Mar;50(3):917-21. doi: 10.1128/AAC.50.3.917-921.2006. Antimicrob Agents Chemother. 2006. PMID: 16495251 Free PMC article.
-
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13. Int J Antimicrob Agents. 2008. PMID: 18790613
Cited by
-
Clinical utility of fungal culture and antifungal susceptibility in cats and dogs with histoplasmosis.J Vet Intern Med. 2023 May-Jun;37(3):998-1006. doi: 10.1111/jvim.16725. Epub 2023 Apr 24. J Vet Intern Med. 2023. PMID: 37092675 Free PMC article.
-
Cladosporium spp. endogenous endophthalmitis simulating the classic "headlight-in-the-fog" appearance of active toxoplasmosis.Oman J Ophthalmol. 2022 Nov 2;15(3):379-381. doi: 10.4103/ojo.ojo_459_20. eCollection 2022 Sep-Dec. Oman J Ophthalmol. 2022. PMID: 36760965 Free PMC article.
-
Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation.Cureus. 2022 Nov 21;14(11):e31762. doi: 10.7759/cureus.31762. eCollection 2022 Nov. Cureus. 2022. PMID: 36569688 Free PMC article.
-
New Perspectives on Antimicrobial Agents: Isavuconazole.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0017722. doi: 10.1128/aac.00177-22. Epub 2022 Aug 15. Antimicrob Agents Chemother. 2022. PMID: 35969068 Free PMC article. Review.
-
Fungal keratitis caused by Pseudallescheria boydii: clinical and mycological characteristics.J Ophthalmic Inflamm Infect. 2021 Sep 24;11(1):30. doi: 10.1186/s12348-021-00255-1. J Ophthalmic Inflamm Infect. 2021. PMID: 34557976 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous